Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.56% | $2.05M | €461.36B | 63.55% | 76 Outperform | |
| Royal Bank Of Canada | 1.74% | $1.39M | $241.39B | 45.29% | 75 Outperform | |
| AstraZeneca | 1.63% | $1.30M | £229.75B | 26.56% | 80 Outperform | |
| Siemens | 1.61% | $1.29M | €199.94B | 14.46% | 74 Outperform | |
| Novartis AG | 1.59% | $1.28M | CHF234.28B | 25.89% | 80 Outperform | |
| Commonwealth Bank of Australia | 1.57% | $1.25M | AU$283.47B | 8.04% | 64 Neutral | |
| Schneider Electric | 1.53% | $1.22M | €150.02B | 10.06% | 62 Neutral | |
| Hitachi,Ltd. | 1.47% | $1.18M | ¥25.81T | 38.44% | 77 Outperform | |
| Shell (UK) | 1.42% | $1.13M | £164.82B | 8.98% | 73 Outperform | |
| SAP SE | 1.33% | $1.06M | €192.42B | -39.22% | 66 Neutral |